Anna Suk-Fong Lok, M.D., named assistant dean for clinical research in the Medical School
Lok is responsible for leading and implementing recommendations from the research board of directors to transform the clinical trials enterprise of the academic medical center
On March 17, the University of Michigan Board of Regents approved the appointment of Anna Suk-Fong Lok, M.D., as assistant dean for clinical research in the Medical School, effective March 1. She is the Alice Lohrman Andrews Research Professor in Hepatology within the Department of Internal Medicine and director of clinical hepatology.
In her role as assistant dean, Lok is responsible for leading, championing, and implementing recommendations from the research board of directors to transform the clinical trials enterprise of the academic medical center. She is responsible for the overall leadership and direction, management, and oversight of the network of clinical trials nodes.
Lok earned her medical degree from the University of Hong Kong and advanced her hepatology training under Sheila Sherlock at the Royal Free Hospital in London. She was on the faculty at the University of Hong Kong until she moved to the United States in 1992. She joined the U-M faculty in 1995 as a professor of internal medicine.
Her research, which is funded by the National Institutes of Health, federal and private foundations, and various pharmaceutical companies, focuses on the natural history and treatment of hepatitis B and C, and the prevention of liver cancer. She has published more than 400 papers on viral hepatitis and liver diseases and was recognized by Thomson Reuters as a top 1% most-cited researcher from 2002-12.
Lok has received many awards throughout her career. She has been included in the list of “Best Doctors” and “Who’s Who” for many years. Other recent awards include the Distinguished Scientist Award from the Hepatitis B Foundation in 2008, the Distinguished Women Scientist Award from the American Gastroenterological Association in 2008, the Distinguished Service Award from the American Association for the Study of Liver Diseases in 2011, and the Distinguished Achievement Award from the American Liver Foundation in 2015. She received a Distinguished Mentor Award from the Michigan Institute of Clinical and Health Research in 2012 and an Inspirational Award from the American Medical Association in 2014.
She served as associate editor of Hepatology from 2001-06 and senior associate editor of Gastroenterology from 2011-12. She is currently the president-elect of the American Association for the Study of Liver Diseases.